Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Thursday, 15 June 2017

Nicox to present at the 2017 BIO International Convention

NICOX    


 

Nicox to present at the 2017 BIO International Convention

 

June 15, 2017
Sophia Antipolis, France

Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today announced that Emmet Purtill, Director Business Development, will present at the 2017 BIO International Convention on Thursday June 22 , 2017 at 11:15 a.m. Pacific Time. The conference is being held at the Convention Center in San Diego.

The presentation will be available on Nicox website (www.nicox.com) in "Presentations & Events".

Mr. Purtill will also be available for one-on-one meetings at the conference.

About Nicox

Nicox is an international ophthalmic R&D company utilizing innovative science to maintain vision and improve ocular health. By leveraging its proprietary expertise in nitric oxide donation and other technologies, the Company is developing an extensive portfolio of novel therapies that target multiple ophthalmic conditions, including glaucoma. Nicox currently has an approved NDA product and another product at the pre-approval stage with the U.S. Food and Drug Administration (FDA) and a promising pipeline including next-generation stand-alone nitric-oxide donors, with the potential to treat a range of ophthalmic indications. Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment B: Mid Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes.

For more information on Nicox, its products or pipeline, please visit: www.nicox.com

Analyst coverage

Bryan, Garnier & Co   Hugo Solvet   Paris, France

Invest Securities   Martial Descoutures   Paris, France

Gilbert Dupont   Damien Choplain   Paris, France

Stifel    Christian Glennie   London, UK

 

Upcoming financial and business conferences

 

September 25-27  Cantor Fitzgerald's 3rd Annual Healthcare Conference  New York; US

Contacts

Nicox

Gavin Spencer,

Executive Vice President Corporate Development
T +33 (0)4 97 24 53 00

communications@nicox.com

 

 

Investor Relations

Europe
NewCap

Julien Perez, Valentine Brouchot

T +33 (0)1 44 71 94 94

nicox@newcap.eu

 

 

Media Relations
United Kingdom
Jonathan Birt

T +44 7860 361 746

jonathan.birt@ymail.com

United States
Argot Partners

Melissa Forst

T +1 (212) 600-1902

melissa@argotpartners.com

France
NewCap

Nicolas Merigeau

T +33 (0)1 44 71 94 98

nicox@newcap.eu

 

United States
Argot Partners

Eliza Schleifstein

T +1 (917) 763-8106

eliza@argotpartners.com

Disclaimer

The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.

Nicox S.A.

Drakkar 2
Bât D, 2405 route des Dolines
CS 10313,  Sophia Antipolis
06560 Valbonne,  France
T +33 (0)4 97 24 53 00
F +33 (0)4 97 24 53 99

 



Nicox to present at the 2017 BIO International Convention



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: NICOX, Drakkar D, 2450 route des Dolines BP 313, Sophia Antipolis, Valbonne FR-06560, France
If you would like to unsubscribe and stop receiving these e-mails click here.